You are in: eMedicine Specialties > Pediatrics: Surgery > Otolaryngology Otitis ExternaArticle Last Updated: Mar 14, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Ariel A Waitzman, MD, FRCS(C), Assistant Professor of Otolaryngology, Wayne State University Ariel A Waitzman is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, Canadian Society of Otolaryngology-Head & Neck Surgery, Michigan State Medical Society, and Ontario Medical Association Editors: Orval Brown, MD, Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; John E McClay, MD, Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, Children's Medical Center, University of Texas Southwestern Medical School; Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System; Maureen Strafford, MD, Arnold P Gold Foundation Associate Professor, Departments of Anesthesiology and Pediatrics, Tufts University and Tufts-New England Medical Center Author and Editor Disclosure Synonyms and related keywords: otitis externa, OE, necrotizing otitis externa, NOE, malignant otitis externa, swimmer's ear, cellulitis, Pseudomonas aeruginosa, Staphylococcus aureus, Candida, Aspergillus, otalgia, lymphadenitis, hearing loss, tinnitus INTRODUCTIONBackgroundOtitis externa (OE) is a common disease affecting all age groups.1 OE usually represents an acute bacterial infection of the skin of the ear canal but can be caused by a fungal infection. Although OE rarely causes prolonged problems or serious complications, the infection is responsible for significant pain and acute morbidity. PathophysiologyOE is a superficial infection of the skin in the ear canal. Two common initiating events may lead to OE. If trapped in the ear canal, moisture may cause maceration of the skin and provide a good breeding ground for bacteria. This may occur after swimming (especially in contaminated water) or bathing, hence the common lay-term swimmer's ear. It may also occur in hot humid weather (when OE is more prevalent). The second significant factor is trauma to the ear canal that allows invasion of bacteria into the damaged skin. This often occurs after attempts at cleaning the ear with a cotton swab, paper clip, or any other utensil that can fit into the ear. Once infection is established, an inflammatory response occurs with skin edema. Exudate and pus often appear in the ear canal as well. If severe, the infection may spread and cause a cellulitis of the face or neck. The most common pathogen is Pseudomonas aeruginosa, followed by Staphylococcus aureus, then other gram-negative organisms. Occasionally, fungi, such as Candida or Aspergillus species, cause OE. Necrotizing (or malignant) OE is a complication that occurs in patients who are immunocompromised or in those who have received radiotherapy to the skull base. In this condition, bacteria invade the deep soft tissues and cause osteomyelitis of the temporal bone. This is a life-threatening disorder with an overall mortality rate that approached 50% historically. FrequencyUnited StatesOE is a very common disease that occurs in all regions of the United States. The infection is believed to be more prevalent in hot and humid conditions. InternationalAlthough OE is a very common disease that occurs worldwide, the infection is believed to be more prevalent in hot and humid conditions. Mortality/Morbidity
RaceNo racial disposition is known. SexOE affects both sexes equally. AgeAlthough the infection can affect all age groups, OE appears to be most prevalent in the older pediatric and young adult population. CLINICALHistoryPatients with otitis externa (OE) may complain of the following:
PhysicalCharacteristics of OE present upon physical examination may include the following:
CausesRisk factors for OE include swimming (hence, the commonly used term swimmer's ear), any source of water trapped in the ear canal, trauma to the ear canal, and a hot humid environment.
DIFFERENTIALSOtitis Media
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Neomycin, polymyxin B, hydrocortisone (Cortisporin Otic) |
|---|---|
| Description | Antibacterial and anti-inflammatory solution for otic use. Treats superficial bacterial infections of external auditory canal. |
| Adult Dose | 4-5 gtt instilled to affected ear qid |
| Pediatric Dose | 4 gtt instilled to affected ear qid |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Extended use can lead to resistant infections and thinning or atrophy of skin; use with caution in patients with perforated TMs because of possible ototoxicity; as many as one third of patients may develop allergic hypersensitivity to neomycin component with redness and inflammation that may mimic persisting infection; a few patients have more severe local reaction |
| Drug Name | Ofloxacin (Floxin otic) |
|---|---|
| Description | Pyridine carboxylic acid derivative with broad-spectrum bactericidal effect. |
| Adult Dose | 5-10 gtt instilled to affected ear bid |
| Pediatric Dose | 5 gtt instilled to affected ear bid |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Superinfections (usually fungal) may occur with prolonged or repeated antibiotic use |
| Drug Name | Ciprofloxacin (Ciloxan, Cipro HC Otic) |
|---|---|
| Description | Fluoroquinolone with activity against pseudomonads, streptococci, MRSA, Staphylococcus epidermidis, and most gram-negative organisms but with no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth. |
| Adult Dose | 3-5 gtt instilled to affected ear bid |
| Pediatric Dose | 3 gtt instilled to affected ear bid |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Superinfections (usually fungal) may occur with prolonged or repeated antibiotic use |
| Drug Name | Tobramycin and dexamethasone (TobraDex) |
|---|---|
| Description | Tobramycin interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits, which results in defective bacterial cell membrane. Dexamethasone decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability. |
| Adult Dose | 5 gtt instilled to affected ear bid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Effects decreased when used concurrently with gentamicin |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Probably should not use when eardrum perforation or ventilation tube is present because of possible ototoxicity |
| Drug Name | Gentamicin (Garamycin) |
|---|---|
| Description | Aminoglycoside antibiotic used for gram-negative bacterial coverage. |
| Adult Dose | 5 gtt instilled to affected ear tid/qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Probably should not use when eardrum perforation or ventilation tube is present because of possible ototoxicity; do not use to treat ocular infections that may become systemic; prolonged or repeated antibiotic therapy may result in bacterial or fungal overgrowth of nonsusceptible organisms and may lead to secondary infections |
| Drug Name | Ciprofloxacin and dexamethasone otic (Ciprodex) |
|---|---|
| Description | Fluoroquinolone that inhibits bacterial DNA synthesis and, consequently, growth by inhibiting DNA gyrase and topoisomerases, which are required for replication, transcription, and translation of genetic material. Quinolones have broad activity against gram-positive and gram-negative aerobic organisms. Has no activity against anaerobes. Dexamethasone decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability. |
| Adult Dose | 4 gtt bid instilled in affected ear or ears for 7 d |
| Pediatric Dose | <6 months: Not established >6 months: Administer as in adults |
| Contraindications | Documented hypersensitivity; viral infections that affect external ear canal |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | For otic use only; warm bottle in hand and shake well before administration; avoid contaminating applicator tip; prolonged use may cause bacterial or fungal overgrowth; rare adverse effects include ear discomfort, ear pain, ear residue, and ear pruritus |
These agents are useful in fungal OE or in mild infections believed to be bacterial. They can also be useful for prevention.
| Drug Name | Acetic acid in aluminium acetate (Domeboro) |
|---|---|
| Description | Aluminium acetate has drying effect. Acetic acid works well in superficial bacterial infections of OE. |
| Adult Dose | 5 gtt instilled to affected ear bid/qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | A - Fetal risk not revealed in controlled studies in humans |
| Precautions | Avoid use when eardrum perforation or ventilation tube is present; for external use only |
| Drug Name | Hydrocortisone and acetic acid otic solution (VoSoL, VoSoL HC) |
|---|---|
| Description | Acetic acid is antibacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic, and antipruritic. Works well in superficial bacterial infections of OE. |
| Adult Dose | 5 gtt bid/qid in canal or on ear wick |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Avoid use when eardrum perforation or ventilation tube is present; for external use only; systemic acidosis may result from absorption |
| Drug Name | Alcohol vinegar otic mix |
|---|---|
| Description | Homemade mix of 50% rubbing alcohol, 25% white vinegar, and 25% distilled water is as effective as pharmaceutical acidifying agents and less expensive. Very useful for prevention and can be used as flushing solution for fungal infections. |
| Adult Dose | 4-6 gtt instilled in affected ear bid/qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | A - Fetal risk not revealed in controlled studies in humans |
| Precautions | Avoid use when eardrum perforation or ventilation tube is present |
These agents are used to treat severe infection or cellulitis. Fluoroquinolones are drugs of choice because of Pseudomonas species coverage.
| Drug Name | Ciprofloxacin (Cipro) |
|---|---|
| Description | Fluoroquinolone with activity against pseudomonads, streptococci, MRSA, S epidermidis, and most gram-negative organisms but with no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth. |
| Adult Dose | 250-500 mg PO bid |
| Pediatric Dose | <18 years: Not recommended >18 years: Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; reduces therapeutic effects of phenytoin; probenecid may increase serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | In prolonged therapy, periodically evaluate organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
Some patients acquire otitis externa (OE) multiple times and should use a preventive strategy.
| Media file 1: Acute otitis externa. The ear canal is red and edematous, and discharge is present. | |
View Full Size Image | Media type: Photo |
Article Last Updated: Mar 14, 2008